NSE:NOVARTIND

Novartis India Limited · NSE · Healthcare · INR · FY for 2026

Figures on this page computed 2026-11-08 13:03 UTC

Last close

n/aINR

Market data

  • 45.4xP/E

    Price / Earnings per Share (diluted)

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    INR
    • computed
    • Computed from the filing for 2026
  • 43.2%ROIC

    NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    INR
    • Computed from the filing for 2026
    • Computed from the filing for 2026
    • Computed from the filing for 2026
    • Computed from the filing for 2026
    • Computed from the filing for 2026
    • Computed from the filing for 2026
  • 26.3%Net margin

    Net Income / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    INR
    • Computed from the filing for 2026
    • Computed from the filing for 2026
  • 23.8%FCF margin

    Free Cash Flow / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    INR
    • Computed from the filing for 2026
    • Computed from the filing for 2026
  • 0.004Debt/equity

    Total Debt / Shareholders' Equity

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    INR
    • Computed from the filing for 2026
    • Computed from the filing for 2026
  • 1.5%Dividend yield
    Source
    computed
    Taken on
    2026-11-08
    Reported in
    INR
    • computed

All from 100

lens 2 of 9

Sales

58.1
2017-03-31 to 2026-03-31100 at the start58.1
Sales: 100.00 on 2017-03-31 to 58.13 on 2026-03-31, down 42%.

Profit

163
2017-03-31 to 2026-03-31100 at the start163
Profit: 100.00 on 2017-03-31 to 162.85 on 2026-03-31, up 63%.

Shares in issue

82.4
2017-03-31 to 2026-03-31100 at the start82.4
Shares in issue: 100.00 on 2017-03-31 to 82.40 on 2026-03-31, down 18%.

Sales is at 58, Profit is at 163, Shares in issue is at 82, against 100 in 2017.

Sales is at 58, Profit is at 163, Shares in issue is at 82, against 100 in 2017.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2026

  • Sales, where the first year is 10058
    Source
    computed
    Statement
    income
    Fiscal year
    2026
    Reported in
    INR
  • Profit, where the first year is 100163
    Source
    computed
    Statement
    income
    Fiscal year
    2026
    Reported in
    INR
  • Shares in issue, where the first year is 10082
    Source
    computed
    Statement
    income
    Fiscal year
    2026
    Reported in
    INR

Filed figures cite the filing they come from; figures marked Market data are quotes as of the date shown. Not a recommendation and not advice.

Past figures are not a forecast. Anything we modelled is labelled as ours. You can lose money on any security.